InsidersTradesSigma
Track the 이엠텍 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 이엠텍 has recorded 8 insider filings. Market capitalisation: €60.5bn. The latest transaction was reported on 21 July 2026 (Purchase). Among the most active insiders: 정승규. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
8 of 8 declarations
이엠텍 is a company listed on the XKRX market, specializing in the health and pharmaceutical sector. It focuses on the development and distribution of pharmaceutical products and medical devices.